Dimension Inx
Because cells alone are not enough.
Tokyo, United States · Founded 2016
- Headquarters
- Tokyo
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- dimensioninx.com
- Last Round
- Series A
- Rounds
- 1
About
Dimension Inx (rebranded as Dimension Bio) is a Chicago-based biotechnology company developing regenerative therapeutics using its BioNidum cell delivery system. By combining cells with biomaterials in a 3D-printed matrix, the platform creates implantable tissue-like therapies. Lead programs target liver failure and bone regeneration, including CMFlex, the first FDA-cleared 3D-printed regenerative bone product.
Summary
Dimension Inx is a Sustainability company based in Tokyo, United States, founded in 2016. Investors include KdT Ventures and Prime Movers Lab.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...